Acute Thrombotic Microangiopathy and Cortical Necrosis Following Administration of Alemtuzumab: A Case Report-Reference-Cited by-同舟云学术

Acute Thrombotic Microangiopathy and Cortical Necrosis Following Administration of Alemtuzumab: A Case Report

Published:2019-05 Issue:5 Volume:73 Page:615-619
ISSN:0272-6386
Container-title:American Journal of Kidney Diseases
language:en
Short-container-title:American Journal of Kidney Diseases

Author:

Liou Ashley A.,Skiver Brent M.,Yates Eric,Persad Paul,Meyer David,Farland Andrew M.,Rocco Michael V.

Publisher

Elsevier BV

Subject

Nephrology

Reference20 articles.

1. Alemtuzumab in multiple sclerosis: mechanism of action and beyond;Ruck;Int J Mol Sci,2015

2. Anti-glomerular basement membrane disease after alemtuzumab;Clatworthy;N Engl J Med,2008

3. Case report of anti-glomerular basement membrane disease following alemtuzumab treatment of relapsing-remitting multiple sclerosis;Meyer;Mult Scler Relat Disord,2013

4. Drug-induced thrombotic microangiopathy: a systematic review of published reports;Al-Nouri;Blood,2015

5. Acute renal failure and disseminated intravascular coagulation following an idiosyncratic reaction to alemtuzumab (Campath 1H) or fludarabine;Osborne;Haematologica,2005

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Immunosuppressants against acute kidney injury: what to prefer or to avoid?;Immunopharmacology and Immunotoxicology;2024-03-18

2. Alemtuzumab‐induced immune‐mediated thrombotic thrombocytopenic purpura: A newly described drug‐related autoimmune disease;British Journal of Haematology;2023-12-19

3. RETRACTED: An Innovative Tool for Evidence-Based, Personalized Treatment Trials in Mucopolysaccharidosis;Pharmaceutics;2023-05-22

4. An Update in Drug-Induced Thrombotic Microangiopathy;Frontiers in Medicine;2020-05-22

5. Pulmonary embolism during the third cycle of alemtuzumab in a patient with relapsing multiple sclerosis;Multiple Sclerosis and Related Disorders;2019-10